MAPK3 and systemic sclerosis: As shown in Figure 4A, PD98059 significantly reduced DCFH-DA fluorescence intensity compared to untreated cells (100 ± 15 and 75 ± 8, P <0.05), confirming ERK1/2 implication in ROS production in SSc T cells.